For Immediate Release

January 31, 2014

Sumitomo Chemical Reports
Consolidated Financial Results
For the Nine Months Ended December 31, 2013
The Sumitomo Chemical Group’s sales for the nine months ended December 31, 2013,
were ¥1,606.3 billion, an increase of ¥183.9 billion compared with the same period ofthe previous fiscal year. The Group posted operating income of ¥71.2 billion, ordinary
income of ¥72.6 billion and net income of ¥24.6 billion, all representing year-on-yearincreases.
The Sumitomo Chemical Group’s financial results by business segment for thenine-month period were as follows.
Basic Chemicals
Market prices remained low for methyl methacrylate and raw materials for synthetic
fibers, and shipments of these products also stayed at a low level. Shipments ofaluminum decreased. On the other hand, the correction of the yen’s appreciation had
a positive effect on sales from overseas subsidiaries in yen terms. As a result, thesegment’s sales increased by ¥11.5 billion from the same period of the previous fiscal
year, to ¥205.2 billion. Operating income, however, declined by ¥2.7 billion, to a lossof ¥7.5 billion.
Petrochemicals & Plastics
Market prices for synthetic resins and petrochemical products rose due to higher
feedstock prices, but shipments from overseas subsidiaries decreased due to low
capacity utilization on account of maintenance work at Petro Rabigh. The correctionof the yen’s appreciation had a positive effect on sales from overseas subsidiaries inyen terms. As a result, the segment’s sales increased by ¥65.9 billion from the same
period of the previous fiscal year, to ¥571.4 billion, and operating income improved by¥7.1 billion, to ¥5.4 billion.
IT-related Chemicals
Sales of polarizing film used in liquid crystal displays (LCDs) increased due to growthin demand. A newly-built touchscreen panel facility in South Korea that began
full-fledged operations in the previous year contributed to sales throughout thenine-month period. As a result, including the positive effect of the correction of theyen’s appreciation, the segment’s sales increased by ¥52.2 billion compared with thesame period of the previous fiscal year, to ¥273.5 billion, and operating income grewby ¥22.0 billion, to ¥29.2 billion.
Health & Crop Sciences
In the area of crop protection chemicals, shipments of herbicides and other productsrose in overseas markets due to increased production capacity and expanded sales.
Market prices of the feed additive methionine declined but shipments increased due
to sales expansion. The correction of the yen’s appreciation had a positive effect onsales from overseas subsidiaries in yen terms. As a result, the segment’s sales
increased by ¥36.9 billion compared with the same period of the previous fiscal year,to ¥207.2 billion, and operating income grew by ¥ 5.7 billion, to ¥14.7 billion.

Pharmaceuticals
In Japan, sales of Aimix® (anti-hypertension drug), Metgluco® (biguanide oralhypoglycemic) and Lonasen® (atypical antipsychotic) increased, but overall sales
decreased as a result of a significant decline in shipments of other existing products.
In North America, shipments of Xopenex® (short-acting beta-agonist) fell sharply asmarketing exclusivity ended, but shipments of Latuda® (atypical antipsychotic)
continued to rise, and the correction of the yen’s appreciation had a positive effect onsales from overseas subsidiaries in yen terms. As a result, the segment’s sales
increased by ¥15.5 billion compared with the same period of the previous fiscal year,to ¥307.9 billion, and operating income grew by ¥2.0 billion, to ¥39.2 billion.
OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analysis. The segment’ssales increased by ¥1.8 billion compared with the same period of the previous fiscalyear, to ¥41.0 billion, and operating income decreased by ¥0.5 billion, to ¥5.3 billion.

Summary of Consolidated Results(1) Results of Operations:

Net sales
Operating income
Ordinary income
Income before income taxes
and minority interests
Net income (loss)

Net income (loss) per 1,000 shares

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations by
Business Segment:
Net sales
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income (loss)
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

9 Months ended
December 31，2013
Yen (Millions)
USD (Thousands)*
1,606,250
15,241,010
71,161
675,216
72,643
689,278

9 Months ended
December 31，2012
Yen (Millions)
1,422,311
36,786
37,59763,082
24,553598,558
232,973

29,680(40,693)Yen
15,021

USD*
143

Yen(24,894)

Yen (Millions)
148,654

USD (Thousands)*
1,410,513

Yen (Millions)(27,675)

As of December 31, 2013
Yen (Millions)
USD (Thousands)*
2,823,891
26,794,677
914,172
8,674,182

As of March 31, 2013
Yen (Millions)
2,472,091
747,482

9 Months ended
December 31，2013
Yen (Millions)
USD (Thousands)*
93,991
891,840(124,376)(1,180,150)
57,331
543,989
162,739
1,544,160

9 Months ended
December 31，2012
Yen (Millions)
70,043(138,096)
42,785
122,519

9 Months ended
December 31，2013
Yen (Millions)
USD (Thousands)*

9 Months ended
December 31，2012
Yen (Millions)205,209571,424
273,529
207,178
307,938
40,972
1,606,250

1,947,139
5,421,994
2,595,398
1,965,822
2,921,890
388,767
15,241,010

193,674
505,510221,286
170,248
292,431
39,162
1,422,311(7,475)
5,415
29,18914,65339,2085,255(15,084)
71,161(70,927)
51,381
276,962
139,036
372,028
49,862(143,126)
675,216(4,756)(1,659)7,227
8,912
37,2505,774(15,962)
36,786(Note)*:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥105.39= $1 prevailing on December 31, 2013.